This test is most useful if any of these apply to you.
If you have ever wondered whether contaminated tap water, a job around industrial chemicals, or years of everyday product use left something behind in your body, this is the test that can actually show it. It measures a specific pollutant that most standard blood panels ignore completely.
This is a newer, research-oriented measurement without agreed-upon clinical cutoffs, so a single number will not diagnose a disease. What it can do is confirm how much of this chemical you carry, which is information no cholesterol or liver panel gives you on its own.
n-PFOA (linear perfluorooctanoic acid) is a synthetic chemical in the family known as PFAS, the same group nicknamed forever chemicals because they resist breaking down. The word linear simply means it is the straight-chain version of the molecule, which is the form that dominates in human blood. Across studies of blood samples from adults, roughly 97% of the total PFOA present is typically this linear form.
Your body does not make this chemical. Every bit in your blood came from outside, mostly through drinking water and food, with smaller contributions from household dust, consumer products, and some personal care products. Because your body clears it so slowly, a blood measurement mostly reflects the exposure you have accumulated over the past several years, not just what you encountered last week.
One consequence of that slow clearance is why the linear form predominates. The branched versions of PFOA leave the body through the kidneys faster, so the straight-chain form is left behind and concentrates in blood. This is a measure of internal exposure and retention, not of any normal body process like blood sugar or liver enzyme release.
The single most consistent human finding is that higher blood levels of this chemical track with higher total and LDL cholesterol. In a healthy British group followed across three checkups over 18 years, higher blood PFOA was linked to higher total cholesterol and LDL (the cholesterol most tied to heart disease). That same study also reported lower HDL, but across larger pooled analyses the HDL link is inconsistent and often absent, so it should not be treated as settled. The link with total and LDL cholesterol shows up in both one-time snapshots and long-term studies.
The size of the effect is real but modest. In one study of prediabetic adults, each doubling of the starting PFOA level was tied to about 6 mg/dL higher total cholesterol, larger than the roughly 2 mg/dL per step seen when many studies are pooled, so treat it as a study-specific figure. In that same group, people above the median had roughly twice the risk of developing high triglycerides (a hazard ratio of 1.90), though the triglyceride link is not consistently found across studies. In fluoropolymer workers, a rise in PFOA was associated with about 1% higher total cholesterol and about 1.4% higher apolipoprotein B, a protein that carries cholesterol particles.
What this means for you: if your cholesterol is creeping up without an obvious diet or genetic explanation, a high level here points to a possible outside contributor worth knowing about. It does not replace a standard lipid workup, but it can add context that cholesterol numbers alone cannot.
The most clinically serious association, though based on fewer studies, is with kidney cancer. In a large prospective cancer-screening study, each doubling of blood PFOA measured before diagnosis was linked to about 1.7 times the odds of renal cell carcinoma, the main type of kidney cancer. People in the highest quarter of exposure had about 2.63 times the risk of those in the lowest quarter.
That association held up even after accounting for other PFAS chemicals, for kidney function, and for cancers diagnosed at least 8 years after the blood was drawn, which makes reverse causation less likely. A separate community study near a chemical plant also found higher kidney and testicular cancer risk with higher estimated exposure. Not every study agrees, though: a later study in a more racially diverse population did not reproduce the overall link, and a recent pooled analysis found no clear net effect. The evidence is credible but narrower and less consistent than the cholesterol data.
Higher blood PFOA is fairly consistently tied to small rises in liver enzymes, especially ALT (alanine aminotransferase, an enzyme that leaks into blood when liver cells are stressed). In a large community cohort, moving from the lowest to the highest cumulative exposure group was associated with about a 6% higher ALT and 16% higher odds of an above-normal ALT reading.
Importantly, these changes are subtle and mostly stayed below the level of actual diagnosed liver disease. Large studies did not find a clear increase in clinically diagnosed liver conditions. So a high level here is a nudge to watch liver markers, not evidence that your liver is failing.
Beyond cholesterol and the liver, the evidence becomes more mixed and population-specific. In 1-year-old children, higher PFOA was tied to noticeably weaker antibody responses to routine vaccines, a signal that this chemical may dampen immune function during early life. In umbilical cord blood, PFOA was among the most abundant PFAS and showed a modest inverse link with one thyroid hormone.
Broader research also connects PFAS exposure, including PFOA, to some reproductive and developmental outcomes such as lower birth weight, and in midlife women to a higher chance of developing diabetes. These are associations from specific groups rather than settled cause-and-effect for any single person, so treat them as reasons the chemical matters, not as predictions about your own health.
Some findings look confusing at first. Two large studies found no increase in cardiovascular disease with higher PFOA, and one even found a slight inverse link. In young girls, higher PFOA was tied to lower body weight. This is not a simple good-number, bad-number marker. It is an exposure indicator, and exposure interacts with body size, kidney clearance, and reverse-cause patterns in ways that can flip the apparent direction for certain outcomes. The steadiest, best-replicated human signal remains the link with higher cholesterol; the scattered opposite findings mostly reflect confounding and the fact that this measures a pollutant burden, not a body function with a clean healthy range.
Understanding a result means understanding the source. Contaminated drinking water drives the highest exposures. In one heavily affected Italian region, adolescents and young adults had a median blood PFOA of 44.4 ng/mL, far above the roughly 1 to 2 ng/mL background levels typically seen in adults without a known contamination source. Even low water contamination can meaningfully raise blood levels over time.
For most people without a known water problem, diet is the largest everyday contributor, with added input from household dust, consumer products, and, for some people, personal care products. Indoor environments matter too: in senior care facilities, dust and blood PFAS levels tracked together. Your result reflects the sum of all these routes filtered through how quickly your body clears the chemical.
This chemical leaves the body over years, not days. Estimated half-lives (the time for the level to fall by half if exposure stopped) generally land around 2 to 4 years, with a broad reported range of about 1.48 to 5.1 years across studies, though some researchers argue the true average may be closer to 2 years once ongoing background exposure is taken into account. That means a single reading is quite stable over months and mostly captures your accumulated burden.
That slow decline is exactly why tracking matters. A baseline tells you where you stand today. If you remove a suspected source, such as switching off contaminated water, retesting in 6 to 12 months and again the next year lets you watch the level fall and confirm the change is working. After contaminated water was removed in one Italian cohort, blood levels dropped by a median of about 62% over roughly 4 years. Because this is a research-grade marker without standardized personal thresholds, a trend line you build over time is far more useful than any one value compared to a lab range.
A few factors can make one reading hard to interpret. The most important ones are physiological rather than momentary, so ordinary rules like fasting matter little here.
A high level is a prompt to investigate your surroundings and your other labs, not a diagnosis. The most useful next step is to identify the source: test your drinking water, review occupational exposure, and consider a broader PFAS panel, since these chemicals usually travel in mixtures and PFOA alone underrepresents your total burden.
Pair the result with the labs that show possible downstream effects: a full lipid panel, ALT and other liver enzymes, and kidney function markers. A pattern of high exposure alongside rising cholesterol or liver enzymes is more actionable than any single number. If your level is very high or you have a known contamination history, an occupational or environmental medicine specialist, or a toxicologist, can help interpret it in context and coordinate monitoring over the years it takes the level to decline.
Evidence-backed interventions that affect your n-PFOA level
Linear PFOA (n-PFOA) is best interpreted alongside these tests.
Linear PFOA (n-PFOA) is included in these pre-built panels.